Rapamycin potentiates cytotoxicity by docetaxel possibly through downregulation of Survivin in lung cancer cells
<p>Abstract</p> <p>Background</p> <p>To elucidate whether rapamycin, the inhibitor of mTOR (mammalian target of rapamycin), can potentiate the cytotoxic effect of docetaxel in lung cancer cells and to probe the mechanism underlying such enhancement.</p> <p>M...
Main Authors: | Li Hui, Wang Jiahe, Niu Huiyan, He Ping |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-03-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Online Access: | http://www.jeccr.com/content/30/1/28 |
Similar Items
-
Enhancement of docetaxel-induced cytotoxicity and apoptosis by all-trans retinoic acid (ATRA) through downregulation of survivin (BIRC5), MCL-1 and LTbeta-R in hormone- and drug resistant prostate cancer cell line, DU-145
by: Karabulut Bulent, et al.
Published: (2008-09-01) -
Downregulation of PTPRT elevates the expression of survivin and promotes the proliferation, migration, and invasion of lung adenocarcinoma
by: Chao Chen, et al.
Published: (2024-01-01) -
MicroRNA-138 Increases Chemo-Sensitivity of Glioblastoma through Downregulation of Survivin
by: Ji-Young Yoo, et al.
Published: (2021-07-01) -
Knockdown of BAP31 Overcomes Hepatocellular Carcinoma Doxorubicin Resistance through Downregulation of Survivin
by: Jingjing Liu, et al.
Published: (2023-04-01) -
MS‐275 potentiates the effect of YM‐155 in lung adenocarcinoma via survivin downregulation induced by miR‐138 and miR‐195
by: Bai‐Ling Luo, et al.
Published: (2019-06-01)